Cargando…
Prevention of Alzheimer's disease in high risk groups: statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein E epsilon 4
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2983440/ https://www.ncbi.nlm.nih.gov/pubmed/21062519 http://dx.doi.org/10.1186/alzrt55 |
| _version_ | 1782191883315838976 |
|---|---|
| author | Pollen, Daniel A Baker, Stephen Hinerfeld, Douglas Swearer, Joan Evans, Barbara A Evans, James E Caselli, Richard Rogaeva, Ekaterina St George-Hyslop, Peter Moonis, Majaz |
| author_facet | Pollen, Daniel A Baker, Stephen Hinerfeld, Douglas Swearer, Joan Evans, Barbara A Evans, James E Caselli, Richard Rogaeva, Ekaterina St George-Hyslop, Peter Moonis, Majaz |
| author_sort | Pollen, Daniel A |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2983440 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2010 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-29834402011-04-29 Prevention of Alzheimer's disease in high risk groups: statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein E epsilon 4 Pollen, Daniel A Baker, Stephen Hinerfeld, Douglas Swearer, Joan Evans, Barbara A Evans, James E Caselli, Richard Rogaeva, Ekaterina St George-Hyslop, Peter Moonis, Majaz Alzheimers Res Ther Review BioMed Central 2010-10-29 /pmc/articles/PMC2983440/ /pubmed/21062519 http://dx.doi.org/10.1186/alzrt55 Text en Copyright ©2010 BioMed Central Ltd |
| spellingShingle | Review Pollen, Daniel A Baker, Stephen Hinerfeld, Douglas Swearer, Joan Evans, Barbara A Evans, James E Caselli, Richard Rogaeva, Ekaterina St George-Hyslop, Peter Moonis, Majaz Prevention of Alzheimer's disease in high risk groups: statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein E epsilon 4 |
| title | Prevention of Alzheimer's disease in high risk groups: statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein E epsilon 4 |
| title_full | Prevention of Alzheimer's disease in high risk groups: statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein E epsilon 4 |
| title_fullStr | Prevention of Alzheimer's disease in high risk groups: statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein E epsilon 4 |
| title_full_unstemmed | Prevention of Alzheimer's disease in high risk groups: statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein E epsilon 4 |
| title_short | Prevention of Alzheimer's disease in high risk groups: statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein E epsilon 4 |
| title_sort | prevention of alzheimer's disease in high risk groups: statin therapy in subjects with psen1 mutations or heterozygosity for apolipoprotein e epsilon 4 |
| topic | Review |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2983440/ https://www.ncbi.nlm.nih.gov/pubmed/21062519 http://dx.doi.org/10.1186/alzrt55 |
| work_keys_str_mv | AT pollendaniela preventionofalzheimersdiseaseinhighriskgroupsstatintherapyinsubjectswithpsen1mutationsorheterozygosityforapolipoproteineepsilon4 AT bakerstephen preventionofalzheimersdiseaseinhighriskgroupsstatintherapyinsubjectswithpsen1mutationsorheterozygosityforapolipoproteineepsilon4 AT hinerfelddouglas preventionofalzheimersdiseaseinhighriskgroupsstatintherapyinsubjectswithpsen1mutationsorheterozygosityforapolipoproteineepsilon4 AT swearerjoan preventionofalzheimersdiseaseinhighriskgroupsstatintherapyinsubjectswithpsen1mutationsorheterozygosityforapolipoproteineepsilon4 AT evansbarbaraa preventionofalzheimersdiseaseinhighriskgroupsstatintherapyinsubjectswithpsen1mutationsorheterozygosityforapolipoproteineepsilon4 AT evansjamese preventionofalzheimersdiseaseinhighriskgroupsstatintherapyinsubjectswithpsen1mutationsorheterozygosityforapolipoproteineepsilon4 AT casellirichard preventionofalzheimersdiseaseinhighriskgroupsstatintherapyinsubjectswithpsen1mutationsorheterozygosityforapolipoproteineepsilon4 AT rogaevaekaterina preventionofalzheimersdiseaseinhighriskgroupsstatintherapyinsubjectswithpsen1mutationsorheterozygosityforapolipoproteineepsilon4 AT stgeorgehysloppeter preventionofalzheimersdiseaseinhighriskgroupsstatintherapyinsubjectswithpsen1mutationsorheterozygosityforapolipoproteineepsilon4 AT moonismajaz preventionofalzheimersdiseaseinhighriskgroupsstatintherapyinsubjectswithpsen1mutationsorheterozygosityforapolipoproteineepsilon4 |